ProMIS Neurosciences (PMN) Return on Capital Employed [ROCE] (2022 - 2026)
ProMIS Neurosciences' Return on Capital Employed [ROCE] was -79.27% in Q2 2026, up 1521.75 percentage points from -1601.02% a year earlier and up 51.36 percentage points from the prior quarter.
Powered by 
Analysis
ProMIS Neurosciences (PMN) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at ProMIS Neurosciences came in at -1105.88%, down 986.09 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a three-year change of -711.13 percentage points (FY2022 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -119.80% in FY2024 (+1426.75 pp), -1546.54% in FY2023 (-1151.79 pp) and -394.75% in FY2022.
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2022.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last six quarters, with an average year-over-year change of +12.38 percentage points.
- Per Business Quant data, PMN's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -130.62% (Q1 2026), -819.00% (Q4 2025) and -1081.58% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | ProMIS Neurosciences | 84.30 Mn | -54.60 Mn | - | -79.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.27% |
| Mar 31, 2026 | -130.62% |
| Dec 31, 2025 | -819.00% |
| Sep 30, 2025 | -1,081.58% |
| Jun 30, 2025 | -1,601.02% |
| Mar 31, 2025 | -168.63% |
| Dec 31, 2024 | -86.33% |
| Sep 30, 2024 | -142.37% |
| Mar 31, 2024 | -218.41% |
| Dec 31, 2023 | -222.93% |
| Sep 30, 2022 | -414.03% |
API Access
ProMIS Neurosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PMN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();